Association Between Nutrients and Cardiovascular Diseases

Amir      Shakarami
Abstract

Cardiovascular diseases (CVD) constitute a leading cause of global mortality. Inflammation and oxidative stress are key molecular underpinnings of CVD pathogenesis. This comprehensive review explores the multifaceted role of nutrients in cardiovascular health beyond their impact on cardiac events. The manuscript examines the influence of macronutrients such as fats and carbohydrates, as well as micronutrients including vitamins and folate, on CVD. Additionally, the interplay between dietary supplements and CVD risk reduction is investigated. The purpose of this manuscript is to provide a comprehensive overview of the diverse mechanisms through which nutrients contribute to cardiovascular well-being, addressing both cardioprotective effects and their broader implications. Through an analysis of pertinent studies, we illuminate the complex relationship between nutrition, lifestyle, and cardiovascular health, underscoring the significance of a holistic approach to CVD prevention and management.
[1]
Hoyert DL, et al. 75 years of mortality in the United States, 1935-2010. NCHS Data Brief  2012; (88): 1-8.
 [PMID: 22617094]

[2]
Sacks FM, Lichtenstein AH, Wu JHY, et al. Dietary fats and cardiovascular disease: A presidential advisory from the American heart association. Circulation  2017; 136(3): e1-e23.

[3]
Mangge H, Becker K, Fuchs D, Gostner JM, et al. Antioxidants, inflammation and cardiovascular disease. World J Cardiol  2014; 6(6): 462-77.

[4]
Panth N, Paudel KR, Parajuli K, et al. Reactive oxygen species: A key hallmark of cardiovascular disease. Adv Med  2016; 9152732.
 [http://dx.doi.org/10.1155/2016/9152732]

[5]
 Effect of diet on vascular health-Reviews in Clinical Gerontology- Cambridge Core. Available form: https://www.cambridge.org/core/journals/reviews-in-clinical-gerontology/article/abs/effect-of-diet-on-vascularhealth/31C24BAE02734707AAEE2F4ABF7978CE

[6]
Keys A, et al. Seven Countries: A multivariate analysis of death and coronary heart disease Seven Countries. Harvard University Press 2013.

[7]
Karam G, Agarwal A, Sadeghirad B, et al. Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: Systematic review and network meta-analysis. BMJ  2023; 380: e072003.

[8]
Sunkara A, Raizner A, et al. Supplemental vitamins and minerals for cardiovascular disease prevention and treatment. Methodist DeBakey Cardiovasc J  2019; 15(3): 179-84.

[9]
Gheini A, Pourya A, Pooria A, et al. Atrial fibrillation and ventricular tachyarrhythmias: Advancements for better outcomes. Cardiovasc Hematol Disord Drug Targets  2021; 20(4): 249-59.
 [http://dx.doi.org/10.2174/1871529X20666201001143907] [PMID: 33001020]

[10]
Mente A, de Koning L, Shannon HS, et al. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med  2009; 169(7): 659-69.

[11]
Ghafarzadeh M, Shakarami A, Yari F, Namdari P, et al. The comparison of side effects of methyldopa, amlodipine, and metoprolol in pregnant women with chronic hypertension. Hypertens Pregnancy  2020; 39(3): 314-8.
 [http://dx.doi.org/10.1080/10641955.2020.1766489] [PMID: 32420783]

[12]
Siri-Tarino PW, Chiu S, Bergeron N, Krauss RM, et al. Saturated fats versus polyunsaturated fats versus carbohydrates for cardiovascular disease prevention and treatment. Annu Rev Nutr  2015; 35(1): 517-43.
 [http://dx.doi.org/10.1146/annurev-nutr-071714-034449] [PMID: 26185980]

[13]
Yu E, Rimm E, Qi L, et al. Diet, lifestyle, biomarkers, genetic factors, and risk of cardiovascular disease in the nurses’ health studies. Am J Public Health  2016; 106(9): 1616-23.

[14]
Widmer RJ, Flammer AJ, Lerman LO, Lerman A, et al. The mediterranean diet, its components, and cardiovascular disease. Am J Med  2015; 128(3): 229-38.

[15]
Gheini A, Shakarami A, Namdari P, Namdari M, Pooria A, et al. Frequency of recurrence of peripheral artery disease among angioplasty and stenting patients. Ann Med Surg  2021; 72: 103146.
 [http://dx.doi.org/10.1016/j.amsu.2021.103146] [PMID: 34925825]

[16]
Merigliano C, Mascolo E, Burla R, Saggio I, Vernì F, et al. The relationship between vitamin B-6, diabetes and cancer. Front Genet  2018; 9: 388.
 [http://dx.doi.org/10.3389/fgene.2018.00388] [PMID: 30271425]

[17]
Ulvik A, Midttun Ø, McCann A, et al. Tryptophan catabolites as metabolic markers of vitamin B-6 status evaluated in cohorts of healthy adults and cardiovascular patients. Am J Clin Nutr  2020; 111(1): 178-86.
 [http://dx.doi.org/10.1093/ajcn/nqz228] [PMID: 31557280]

[18]
Gostner JM, Kurz K, Fuchs D, et al. The significance of tryptophan metabolism and vitamin B-6 status in cardiovascular disease. Am J Clin Nutr  2020; 111(1): 8-9.
 [http://dx.doi.org/10.1093/ajcn/nqz291] [PMID: 31724698]

[19]
Zhao LG, Shu XO, Li HL, et al. Prospective cohort studies of dietary vitamin B6 intake and risk of cause-specific mortality. Clin Nutr  2019; 38(3): 1180-7.
 [http://dx.doi.org/10.1016/j.clnu.2018.04.016] [PMID: 29764693]

[20]
Han J, Zhao C, Cai J, Liang Y, et al. Comparative efficacy of vitamin supplements on prevention of major cardiovascular disease: Systematic review with network meta-analysis. Complement Ther Clin Pract  2020; 39: 101142.
 [http://dx.doi.org/10.1016/j.ctcp.2020.101142] [PMID: 32379630]

[21]
Lan X, Dang SN, Zhao YL, Yan H, Yan H, et al. Meta-analysis on effect of combined supplementation of folic acid, vitamin B12 and B6 on risk of cardio-cerebrovascular diseases in randomized control trials. Zhonghua Liu Xing Bing Xue Za Zhi  2016; 37(7): 1028-34.
 [http://dx.doi.org/10.3760/cma.j.issn.0254-6450.2016.07.024] [PMID: 27453118]

[22]
Pooria A, Pourya A, Gheini A, et al. Postoperative complications associated with coronary artery bypass graft surgery and their therapeutic interventions. Future Cardiologyvol  2020; 16(5)

[23]
Amer M, Qayyum R, et al. The relationship between 25-Hydroxyvitamin D and homocysteine in asymptomatic adults. The  Journal of Clinical Endocrinology & Metabolism  2014; 99(2): 633-8.

[24]
Yuyun MF, Ng LL, Ng GA, et al. Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy? Microvasc Res  2018; 119: 7-12.
 [http://dx.doi.org/10.1016/j.mvr.2018.03.012] [PMID: 29596860]

[25]
Chen CH, Yang WC, Hsiao YH, Huang SC, Huang YC, et al. High homocysteine, low vitamin B-6, and increased oxidative stress are independently associated with the risk of chronic kidney disease. Nutrition  2016; 32(2): 236-41.
 [http://dx.doi.org/10.1016/j.nut.2015.08.016] [PMID: 26526964]

[26]
Qasim M, Bukhari SA, Ghani MJ, et al. Relationship of oxidative stress with elevated level of DNA damage and homocysteine in cardiovascular disease patients. Pak J Pharm Sci  2016; 29(6) (Suppl.): 2297-302.

[27]
Qin X, Li Y, Sun N, et al. Elevated homocysteine concentrations decrease the antihypertensive effect of angiotensin-converting enzyme inhibitors in hypertensive patients. arteriosclerosis, thrombosis, and vascular biology  2017; 37: 166-72.

[28]
Yang Q, He G-W, et al. Imbalance of homocysteine and H2S: Significance, mechanisms, and therapeutic promise in vascular injury. Oxidative Medicine and Cellular Longevity 2019.

[29]
Mao X, Xing X, Xu R, et al. Folic acid and vitamins D and B12 correlate with homocysteine in chinese patients with type-2 diabetes mellitus, hypertension, or cardiovascular disease. Medicine  2016; 95(6): e2652.
 [http://dx.doi.org/10.1097/MD.0000000000002652] [PMID: 26871790]

[30]
 Recent insights into the role of vitamin B12 and Vitamin D upon cardiovascular mortality: A systematic review. Available from: https://www.researchgate.net/publication/329308231_Recent_Insights_into_the_Role_of_Vitamin_B12_and_Vitamin_D_upon_Cardiovascular_Mortality_A_Systematic_Review

[31]
Boachie J, Adaikalakoteswari A, Samavat J, Saravanan P, et al. Low vitamin B12 and lipid metabolism: evidence from pre-clinical and clinical studies. Nutrients  2020; 12(7): 1925.

[32]
Al-Musharaf S, Aljuraiban GS. Danish Hussain S, Alnaami AM, Saravanan P, Al-Daghri N, et al. Low serum vitamin B12 levels are associated with adverse lipid profiles in apparently healthy young saudi women. Nutrients  2020; 12(8): 2395.
 [http://dx.doi.org/10.3390/nu12082395] [PMID: 32785129]

[33]
Pawlak R, et al. Is vitamin B12 deficiency a risk factor for cardiovascular disease in vegetarians? American J Preven Med  2015; 48(6): E11-26.

[34]
Foscolou A, Rallidis LS, Tsirebolos G, et al. The association between homocysteine levels, Mediterranean diet and cardiovascular disease: a case-control study. Int J Food Sci Nutr  2019; 70(5): 603-11.
 [http://dx.doi.org/10.1080/09637486.2018.1547688] [PMID: 30501542]

[35]
Bivona G, Agnello L, Ciaccio M, et al. The immunological implication of the new vitamin D metabolism. Cent Eur J Immunol  2018; 43(3): 331-4.
 [http://dx.doi.org/10.5114/ceji.2018.80053] [PMID: 30588177]

[36]
Zhao H, Li Y, Wu M, et al. Seasonal variation in the frequency of venous thromboembolism: An updated result of a meta-analysis and systemic review. Phlebology  2020; 35(7): 480-94.
 [http://dx.doi.org/10.1177/0268355519897650] [PMID: 32036737]

[37]
Grant WB, Bhattoa HP, Boucher BJ, et al. Seasonal variations of U.S. mortality rates: Roles of solar ultraviolet-B doses, vitamin D, gene exp ression, and infections. J Steroid Biochem Mol Biol  2017; 173: 5-12.
 [http://dx.doi.org/10.1016/j.jsbmb.2017.01.003] [PMID: 28088363]

[38]
Yang J, Zhou M, Ou CQ, et al. Seasonal variations of temperature-related mortality burden from cardiovascular disease and myocardial infarction in China. Environ Pollut  2017; 224: 400-6.
 [http://dx.doi.org/10.1016/j.envpol.2017.02.020] [PMID: 28222981]

[39]
Schwarz N, Nicholls SJ, Psaltis PJ, et al. Vitamin D and cardiovascular disease. Heart Lung and Circulation  2018; 27(8): 903-6.

[40]
Carrara D, Bruno RM, Bacca A, et al. Cholecalciferol treatment downregulates renin–angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D. J Hypertens  2016; 34(11): 2199-205.
 [http://dx.doi.org/10.1097/HJH.0000000000001072] [PMID: 27648718]

[41]
Rodríguez AJ, Scott D, Srikanth V, Ebeling P, et al. Effect of vitamin D supplementation on measures of arterial stiffness: A systematic review and meta-analysis of randomized controlled trials. Clin Endocrinol  2016; 84(5): 645-57.

[42]
Adamczak M, Surma S, Więcek A, et al. Vitamin D and arterial hypertension: Facts and myths. Curr Hypertens Rep  2020; 22(8): 57.
 [http://dx.doi.org/10.1007/s11906-020-01059-9] [PMID: 32671631]

[43]
Ni W, Watts SW, Ng M, Chen S, Glenn DJ, Gardner DG, et al. Elimination of vitamin D receptor in vascular endothelial cells alters vascular function. Hypertension  2014; 64(6): 1290-8.

[44]
Grübler MR, Gaksch M, Kienreich K, et al. Effects of vitamin d supplementation on plasma aldosterone and renin—a randomized placebo‐controlled trial. J Clin Hypertens  2016; 18(7): 608-13.
 [http://dx.doi.org/10.1111/jch.12825] [PMID: 27098193]

[45]
Wong MSK, Delansorne R, Man RYK, Svenningsen P, Vanhoutte PM, et al. Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol  2010; 299(4): H1226-34.
 [http://dx.doi.org/10.1152/ajpheart.00288.2010] [PMID: 20693391]

[46]
Pooria A, Pourya A, Gheini M, et al. Application of tissue-engineered interventions for coronary artery bypass grafts. Future Cardiol  2020; 16(6): 675-85.

[47]
Salem-Sokhn E, Salami A, Fawaz M, Eid AH, El Shamieh SH, et al. Helicobacter pylori interacts with serum vitamin D to influence hypertension. Curr Aging Sci  2021; 14(1): 26-31.

[48]
Zhang D, Cheng C, Wang Y, et al. Effect of vitamin D on blood pressure and hypertension in the general population: An update meta-analysis of cohort studies and randomized controlled trials. Prev Chronic Dis  2020; 17: 190307.
 [http://dx.doi.org/10.5888/pcd17.190307] [PMID: 31922371]

[49]
Qi D, Nie X, Cai J, et al. The effect of vitamin D supplementation on hypertension in non-CKD populations: A systemic review and meta-analysis. Int J Cardiol  2017; 227: 177-86.
 [http://dx.doi.org/10.1016/j.ijcard.2016.11.040] [PMID: 27866065]

[50]
Andrukhova O, Slavic S, Zeitz U, Riesen SC, et al. Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol Endocrinol  2014; 28(1): 53-64.

[51]
Al-Bayyari N, Al-Zeidaneen S, Hailat R, Hamadneh J, et al. Vitamin D3 prevents cardiovascular diseases by lowering serum total homocysteine concentrations in overweight reproductive women: A randomized, placebo-controlled clinical trial. Nutr Res  2018; 59: 65-71.
 [http://dx.doi.org/10.1016/j.nutres.2018.07.012] [PMID: 30442234]

[52]
Shakarami A, et al. An idiopathic case of precordial deep T-wave inversion. Ann Med Surg  2021; 71: 102959.
 [http://dx.doi.org/10.1016/j.amsu.2021.102959] [PMID: 34703593]

[53]
Legarth C, Grimm D, Krüger M, Infanger M, Wehland M, et al. Potential beneficial effects of vitamin D in coronary artery disease. Nutrients  2019; 12(1): 99.
 [http://dx.doi.org/10.3390/nu12010099] [PMID: 31905893]

[54]
Hiemstra TF, Lim K, Thadhani R, Manson JE, et al. Vitamin D and atherosclerotic cardiovascular disease. The journAl of clinicAl endocrinology & Metabolism  2019; 104(9): 4033-50.

[55]
Martinez-Moreno JM, Herencia C, Oca AM, et al. Vitamin D modulates tissue factor and protease‐activated receptor 2 expression in vascular smooth muscle cells. FASEB J  2016; 30(3): 1367-76.
 [http://dx.doi.org/10.1096/fj.15-272872] [PMID: 26700731]

[56]
Safaie N, Rezaee H, Seif Dvati B, Entezari-Maleki T, Vitamin D, et al. Vitamin D deficiency predicts the st elevation type of myocardial infarction in patients with acute coronary syndrome. Iran J Pharm Res  2018; 17 (Suppl.): 73-8.
 [PMID: 29796031]

[57]
Kouvari M, Panagiotakos DB, Chrysohoou C, et al. Dietary vitamin D intake, cardiovascular disease and cardiometabolic risk factors: A sex‐based analysis from the ATTICA cohort study. J Hum Nutr Diet  2020; 33(5): 708-17.
 [http://dx.doi.org/10.1111/jhn.12748] [PMID: 32266756]

[58]
Meems LMG, Cannon MV, Mahmud H, et al. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. J Steroid Biochem Mol Biol  2012; 132(3-5): 282-9.
 [http://dx.doi.org/10.1016/j.jsbmb.2012.06.004] [PMID: 22800987]

[59]
Şeker T, Gür M, Uçar H, et al. Lower serum 25-hydroxyvitamin D level is associated with impaired myocardial performance and left ventricle hypertrophy in newly diagnosed hypertensive patients. Anatol J Cardiol  2015; 15(9): 744-50.

[60]
Qu H, Lin K, Wang H, et al. 1,25(OH) 2 D 3 improves cardiac dysfunction, hypertrophy, and fibrosis through PARP1/SIRT1/mTOR‐related mechanisms in type 1 diabetes. Mol Nutr Food Res  2017; 61(5): 1600338.
 [http://dx.doi.org/10.1002/mnfr.201600338] [PMID: 27561793]

[61]
Qin X, Huo Y, Xie D, Hou F, Xu X, Wang X, et al. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: A meta-analysis of randomized controlled trials. Clinical Nutrition  2013; 32(5): 722-7.

[62]
Pooria A, Azadbakht M, Khoshdani-farahani P, Pourya A, et al. Sigmoid volvulus after CABG surgery. Clin Case Rep  2020; 8(4): 606-11.
 [http://dx.doi.org/10.1002/ccr3.2668] [PMID: 32274020]

[63]
Peng Y, Dong B, Wang Z, et al. Serum folate concentrations and all-cause, cardiovascular disease and cancer mortality: A cohort study based on 1999–2010 National Health and Nutrition Examination Survey (NHANES). Intern J Cardiolog  2016; 219: 136-42.

[64]
Jiang X, Yang F, Tan H, et al. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol  2005; 25(12): 2515-1.

[65]
Herranz B, Marquez S, Guijarro B, Aracil E, et al. Integrin-linked kinase regulates vasomotor function by preventing endothelial nitric oxide synthase uncoupling: Role in atherosclerosis. Circ Res  2012; 110(3): 439-9.

[66]
Kaye AD, Jeha GM, Pham AD, et al. Folic acid supplementation in patients with elevated homocysteine levels. Adv Ther  2020; 37: 4149-64.

[67]
Zhou L, Wen X, Peng Y, Guo M, Zhao L, et al. Red blood cell folate and severe abdominal aortic calcification: Results from the NHANES 2013–2014. Nutr Metab Cardiovasc Dis  2021; 31(1): 186-92.
 [http://dx.doi.org/10.1016/j.numecd.2020.08.020] [PMID: 32988723]

[68]
Ghafarzadeh M, Shakarami A, Yari F, et al. Prevention of preterm labor by isosorbide dinitrate and nitroglycerin patch. Cardiovasc Hematol Disord Drug Targets 2023.

[69]
Li Q, Xu S, Chen X, Zhang X, Li X, et al. Folic acid supplement use and increased risk of gestational hypertension. Hypertension  2020; 76(1): 150-6.

[70]
Liu X, Cui T, Li Y, et al. Vitamin A supplementation in early life enhances the intestinal immune response of rats with gestational vitamin A deficiency by increasing the number of immune cells. PLoS One  2014; 9(12): e114934.
 [http://dx.doi.org/10.1371/journal.pone.0114934] [PMID: 25503794]

[71]
Bitarafan S, Saboor-Yaraghi A, Sahraian M-A, et al. Effect of vitamin A supplementation on fatigue and depression in multiple sclerosis patients: A double-blind placebo-controlled clinical trial. Iran J Allergy Asthma Immunol  2016; 15(1): 13-9.
 [PMID: 26996107]

[72]
Barbalho SM, Goulart RA, Batista GLSA, et al. Vitamin A and inflammatory bowel diseases: From cellular studies and animal models to human disease. Expert Rev Gastroenterol Hepatol  2019; 13(1): 25-35.
 [http://dx.doi.org/10.1080/17474124.2019.1543588] [PMID: 30791845]

[73]
Macaluso FS, Ventimiglia M, Fries W, Viola A, et al. A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis. Digestive and Liver Disease  2020; 52(12): 1461-6.

[74]
Qi Y-J, Niu Q-L, Zhu X-L, Zhao X-Z, Yang W-W, Wang X-J, et al. Relationship between deficiencies in vitamin A and E and occurrence of infectious diseases among children. Eur Rev Med Pharmacol Sci  2016; 20(23): 5009-12.

[75]
Harirchian MH, Mohammadpour Z, Fatehi F, Firoozeh N, Bitarafan S, et al. A systematic review and meta-analysis of randomized controlled trials to evaluating the trend of cytokines to vitamin A supplementation in autoimmune diseases. Clin Nutr  2019; 38(5): 2038-44.
 [http://dx.doi.org/10.1016/j.clnu.2018.10.026] [PMID: 30473441]

[76]
Bruce D, Yu S, Ooi JH, Cantorna MT, et al. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. International Immunology  2011; 23(8): 519-28.

[77]
Hirahara K, Ghoreschi K, Laurence A, Yang XP, Kanno Y, O’Shea JJ, et al. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev  2010; 21(6): 425-34.
 [http://dx.doi.org/10.1016/j.cytogfr.2010.10.006] [PMID: 21084214]

[78]
Ellulu MS, Rahmat A, Patimah I, Khaza’ai H, Abed Y, et al. Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: A randomized controlled trial. Drug Design, Development and Therapy  2015; 9: 3405-12.

[79]
Mottaghi A, Ebrahimof S, Angoorani P, Saboor-Yaraghi A-A, et al. Vitamin A supplementation reduces IL-17 and RORc gene expression in atherosclerotic patients. Scand J Immunol  2014; 80(2): 151-7.

[80]
Shakarami A, Ghafarzadeh M, Yari F, Fathi L, et al. Association between maternal serum uric acid and preeclampsia. Arch Physiol Biochem  2022; 128(6): 1434-7.

[81]
Miller AP, Coronel J, Amengual J, et al. The role of β-carotene and vitamin A in atherogenesis: Evidences from preclinical and clinical studies. Biochim Biophys Acta BBA - Mol Cell Biol Lipids 1865  2020; 158635.
 [http://dx.doi.org/10.1016/j.bbalip.2020.158635]

[82]
Bonet ML, Ribot J, Palou A, et al. Lipid metabolism in mammalian tissues and its control by retinoic acid. Biochim Biophys Acta Mol Cell Biol Lipids  2012; 1821(1): 177-89.
 [http://dx.doi.org/10.1016/j.bbalip.2011.06.001] [PMID: 21669299]

[83]
Izma AZ, Sam LS, Nadeem AM, Russell D, et al. Scavenger receptor structure and function in health and disease. Cells  2015; 4(2): 178-201.

[84]
Relation of serum vitamin A levels to all-cause and cause-specific mortality among older adults in the NHANES III population. Nutrition Metabolism and Cardiovascular Disease  2014; 24(11): 1197-203.

[85]
Makariou SE, Elisaf M, Challa A, Tellis CC, Tselepis AD, Liberopoulos EN, et al. No effect of vitamin D administration plus dietary intervention on emerging cardiovascular risk factors in patients with metabolic syndrome. J Nutr Intermed Metab  2019; 16: 100093.
 [http://dx.doi.org/10.1016/j.jnim.2019.100093]

[86]
Mangione CM, Michael JB, Nicholson WK, et al. US Preventive services task force. vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease and cancer: US preventive services task force recommendation statement. JAMA  2022; 327(23): 2326-33.

[87]
 Vitamin and Mineral Supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the U.S. preventive services task force. Available from: https://www.acpjournals.org/doi/full/10.7326/0003-4819-159-12-201312170-00729?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org

[88]
Min YN, Niu ZY, Sun TT, et al. Vitamin E and vitamin C supplementation improves antioxidant status and immune function in oxidative-stressed breeder roosters by up-regulating expression of GSH-Px gene. Poult Sci  2018; 97(4): 1238-44.
 [http://dx.doi.org/10.3382/ps/pex417] [PMID: 29452404]

[89]
Wallert M, Börmel L, Lorkowski S, et al. Inflammatory diseases and vitamin E-what do we know and where do we go? Mol Nutr Food Res  2021; 65(1): e2000097.

[90]
Aykutoglu G, Tartik M, Darendelioglu E, Ayna A, Baydas G, et al. Melatonin and vitamin E alleviate homocysteine‐induced oxidative injury and apoptosis in endothelial cells. Molecular Biology Reports  2020; 47: 5285-93.

[91]
Cordero Z, Drogan D, Weikert C, Boeing H, et al. Vitamin E and risk of cardiovascular diseases: A review of epidemiologic and clinical trial studies. Crit Rev Food Sci Nutr  2010; 50(5): 420-40.
 [http://dx.doi.org/10.1080/10408390802304230] [PMID: 20373188]

[92]
Munteanu A, Zingg JM, et al. Cellular, molecular and clinical aspects of vitamin E on atherosclerosis prevention. Mol Aspects Med  2007; 28(5-6): 538-90.
 [http://dx.doi.org/10.1016/j.mam.2007.07.001] [PMID: 17825403]

[93]
Moser M, Chun O, et al. Vitamin C and Heart Health: A review based on findings from epidemiologic studies. Int J Mol Sci  2016; 17(8): 1328.
 [http://dx.doi.org/10.3390/ijms17081328] [PMID: 27529239]

[94]
Ashor AM, Lara J, Mathers JC, Siervo M, et al. Effect of vitamin C on endothelial function in health and disease: A systematic review and meta-analysis of randomised controlled trials. RE:view  2014; 235(1): 9-20.

[95]
Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A, et al. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant  2018; 33: iii28-34.

[96]
Isola G, Polizzi A, Muraglie S, Leonardi R, Lo Giudice A, et al. Assessment of vitamin C and antioxidant profiles in saliva and serum in patients with periodontitis and ischemic heart disease. Nutrients  2019; 11(12): 2956.
 [http://dx.doi.org/10.3390/nu11122956] [PMID: 31817129]

[97]
Jayedi A, Rashidy-Pour A, Parohan M, Zargar MS, Shab-Bidar S, et al. Dietary and circulating vitamin C, vitamin E, β-carotene and risk of total cardiovascular mortality: A systematic review and dose-response meta-analysis of prospective observational studies. Public Health Nutr  2019; 22(10): 1872-87.

[98]
Ertunc ME, Hotamisligil GS, et al. Lipid signaling and lipotoxicity in metaflammation: Indications for metabolic disease pathogenesis and treatment. J Lipid Res  2016; 57(12): 2099-114.

[99]
Amirzadegan A, Shakarami A, Borumand MA, Davoodi G, Ghaffari-Marandi N, Jalali A, et al. Correlation between plasma adiponectin levels and the presence and severity of coronary artery disease. J Teh Univ Heart Ctr  2013; 8(3)

[100]
Lim CC, Hayes RB, Ahn J, et al. Mediterranean diet and the association between air pollution and cardiovascular disease mortality risk. Circulation  2019; 139(15): 1766-75.

[101]
Estruch R, Ros E, Salas-Salvadó J, Covas M-I, et al. Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med  2018; 378-e34.

[102]
Konstantinov IE, Mejevoi N, Anichkov NM, et al. Nikolai N. Anichkov and his theory of atherosclerosis. Tex Heart Inst J  2006; 33(4): 417-23.

[103]
Wan EYF, Yu EYT, Chin WY, et al. Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10‐year diabetes cohort study. Diabetes Obes Metab  2020; 22(10): 1777-88.
 [http://dx.doi.org/10.1111/dom.14093] [PMID: 32452623]

[104]
Shaimaa AK, Noha AD, Osama EB, Malak TL, Meabed MH, et al. Effect of vitamin D receptor gene polymorphism on lipid profile in Egyptian children with juvenile idiopathic arthritis.  The Egyptian Rheumatologist  2022; 44(3): 251-5.

[105]
Collins DRJ, Tompson AC, Onakpoya IJ, Roberts N, Ward AM, Heneghan CJ, et al. Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: Systematic review of systematic reviews. BMJ Open  2017; 7(3): e013650.

[106]
Willett WC, et al. Dietary fats and coronary heart disease. J Intern Med  2012; 272(1): 13-24.

[107]
Hooper L, Martin N, Abdelhamid A, Smith GD, et al. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database of Systematic Reviews 2015.

[108]
Volk BM, Laura JK, Freidenreich DJ, Kupchak BR, Saenz C, et al. Effects of step-wise increases in dietary carbohydrate on circulating saturated fatty acids and palmitoleic acid in adults with metabolic syndrome. PLoS ONE  2014; 9(11): e113605.

[109]
Khan SU, Khan MU, Riaz H, Valavoor S, Zhao D, et al. Effects of nutritional supplements and dietary interventions on cardiovascular outcomes: An umbrella review and evidence map. Ann Intern Med  2019; 171(3): 190-8.

[110]
Halcox JP, Banegas JP, Roy C, Dallongeville J, et al. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study. BMC Cardiovasc Disord  2017; 17(1): 160.

[111]
Borén J, Olin K, Lee I, Chait A, Wight TN, Innerarity TL, et al. Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest  1998; 101(12): 2658-64.
 [http://dx.doi.org/10.1172/JCI2265] [PMID: 9637699]

[112]
Toth P, et al. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease. Vasc Health Risk Manag  2016; 12: 171-83.
 [http://dx.doi.org/10.2147/VHRM.S104369] [PMID: 27226718]

[113]
Doi H, Kugiyama K, Oka H, et al. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation  2000; 102(6): 670-6.
 [http://dx.doi.org/10.1161/01.CIR.102.6.670] [PMID: 10931808]

[114]
Brian AF, Kastelein JP, Ray KK, et al. Association of triglyceride-lowering LPL variants and LDL-C–Lowering LDLR variants with risk of coronary heart disease. JAMA  2019; 321(4): 364-73.

[115]
Børge GN, Benn M, Schnohr P, et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA  2007; 298(3): 299-308.

[116]
Gheini A, Pooria A, Pourya A, et al. Evaluating mortality rate and associated parameters in patients with acute coronary syndrome. Cardio Hema Dis Drug Targ  2020; 20(3): 221-6.

[117]
Seidelmann SB, Claggett B, Cheng S, Henglin M, Shah A, Steffen LM, et al. Dietary carbohydrate intake and mortality: A prospective cohort study and meta-analysis. Lan Pub Heal  2018; 3(9): E419-28.

[118]
Jakobsen MU, Dethlefsen C, Joensen AM, et al. Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am J Clin Nutr  2010; 91(6): 1764-8.
 [http://dx.doi.org/10.3945/ajcn.2009.29099] [PMID: 20375186]

[119]
Krauss RM, Blanche PJ, Rawlings RS, Fernstrom HS, Williams PT, et al. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr  2006; 83(5): 1025-31.
 [http://dx.doi.org/10.1093/ajcn/83.5.1025] [PMID: 16685042]

[120]
Micha R, Mozaffarian D, et al. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: A fresh look at the evidence. Lipids  2010; 45(10): 893-905.
 [http://dx.doi.org/10.1007/s11745-010-3393-4] [PMID: 20354806]

[121]
Dehghan M, Mente A, Zhang X, Swaminathan S, Li W, Mohan V, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): A prospective cohort study. The Lancet  2017; 390(10107): 2050-62.

[122]
Pooria A, Pourya A, Gheini A, et al. Animal‐ and human‐based evidence for the protective effects of stem cell therapy against cardiovascular disorders. J Cell Physiol  2019; 234(9): 14927-40.
 [http://dx.doi.org/10.1002/jcp.28330] [PMID: 30811030]

[123]
Ma Y, Su C, Wang H, Wang Z, Liang H, Zhang B, et al. Relationship between carbohydrate intake and risk factors for cardiovascular disease in Chinese adults: Data from the China Health and Nutrition Survey (CHNS). Asia Pac J Clin Nutr  2019; 28(3): 520-32.
 [http://dx.doi.org/10.6133/apjcn.201909_28(3).0011] [PMID: 31464398]
Cite As
Current Cardiology Reviews

Association Between Nutrients and Cardiovascular Diseases

Abstract
